{"id":4972,"date":"2001-11-02T17:49:13","date_gmt":"2001-11-02T16:49:13","guid":{"rendered":"http:\/\/moomango.co.uk\/htb\/?p=4972"},"modified":"2014-06-11T13:57:22","modified_gmt":"2014-06-11T13:57:22","slug":"8th-european-conference-on-clinical-aspects-and-treatment-of-hiv-infection","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/4972","title":{"rendered":"8th European Conference on Clinical Aspects and Treatment of HIV-infection, Athens, 28-31 October 2001"},"content":{"rendered":"<p><strong><a href=\"https:\/\/i-base.info\/htb\/keyword\/ecas-8-athens-2001\">Reports from the conference<\/a><\/strong>.<\/p>\n<ul>\n<li><a title=\"Permanent link to HIV drug resistance can develop under HAART at low levels of viraemia\" href=\"https:\/\/i-base.info\/htb\/4969\" rel=\"bookmark\">HIV drug resistance can develop under HAART at low levels of viraemia<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Combinations of lopinavir\/r and amprenavir in heavily treatment experienced patients\" href=\"https:\/\/i-base.info\/htb\/4968\" rel=\"bookmark\">Combinations of lopinavir\/r and amprenavir in heavily treatment experienced patients<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Further reports of benefits of polylactic acid for facial lipoatrophy\" href=\"https:\/\/i-base.info\/htb\/4951\" rel=\"bookmark\">Further reports of benefits of polylactic acid for facial lipoatrophy<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to GigaHAART study shows benefit of treatment interruption prior to treatment with &gt;7 drugs in highly treatment experienced patients\" href=\"https:\/\/i-base.info\/htb\/4948\" rel=\"bookmark\">GigaHAART study shows benefit of treatment interruption prior to treatment with &gt;7 drugs in highly treatment experienced patients<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Tenofovir DF 907 study\" href=\"https:\/\/i-base.info\/htb\/4966\" rel=\"bookmark\">Tenofovir DF 907 study<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to The Max Cmin 1 trial: indinavir\/ritonavir vs. saquinavir\/ritonavir\" href=\"https:\/\/i-base.info\/htb\/4962\" rel=\"bookmark\">The Max Cmin 1 trial: indinavir\/ritonavir vs. saquinavir\/ritonavir<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to No significant drug interactions found between tenofovir DF and indinavir, lopinavir\/r, lamivudine, or efavirenz\" href=\"https:\/\/i-base.info\/htb\/4959\" rel=\"bookmark\">No significant drug interactions found between tenofovir DF and indinavir, lopinavir\/r, lamivudine, or efavirenz<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Ritonavir corrects drug interaction between efavirenz and saquinavir\" href=\"https:\/\/i-base.info\/htb\/4957\" rel=\"bookmark\">Ritonavir corrects drug interaction between efavirenz and saquinavir<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Lopinavir\/r effective in naive patients after three years of treatment\" href=\"https:\/\/i-base.info\/htb\/4945\" rel=\"bookmark\">Lopinavir\/r effective in naive patients after three years of treatment<\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Reports from the conference. HIV drug resistance can develop under HAART at low levels of viraemia Combinations of lopinavir\/r and amprenavir in heavily treatment experienced patients Further reports of benefits of polylactic acid for facial lipoatrophy GigaHAART study shows benefit &hellip;<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[74,12],"class_list":["post-4972","post","type-post","status-publish","format-standard","hentry","category-conference-reports","tag-ecas-8th-2001","tag-conference-index"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/4972","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=4972"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/4972\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=4972"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=4972"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=4972"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}